A  BlueTree Allied Angels


     Office Locations:

P.O. Box 1323
Wexford, PA 15090
Phone: 724-475-4538
Fax: 888-550-3093



  • Early



  • Communications & Networking
  • Consumer Products & Services
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device
  • Retail & Restaurant
  • Semiconductor
  • Software & Internet



    BlueTree Allied Angels (Allied Angels) is a regional group of accredited investors who desire to invest in regional early-stage companies. The membership meets 10 to 12 times during the year to consider two to four private equity investment opportunities per meeting. Each group investment is treated as a separate LLC/LP. BlueTree Capital Group provides the professional staff to facilitate and manage the Allied Angels organization. BlueTree Capital Group organizes and coordinates the group meetings, the entrepreneur screening process, and the due diligence process, while also providing 'portfolio status reports' to the membership. Characteristics of companies that are attractive to Allied Angels are: Companies headquartered within 250 miles of Pittsburgh or Erie, PA; A minimum of 10 times return expected within 3-5 years; Primary operations in targeted industries aligned with the Allied Angels' membership interest; Investment requirements between $200,000 and $3,000,000; and a pre-money valuation of less than $5,000,000.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Catherine Mott President and CEO
    Christopher Evans Co-Chairman of Member/Partner Committee
    Darrin Grove Chairman of Technology Deal Flow Committee
    Don Morrison Chairman of Deal Flow
    Larry Miller Chairman of Life Sciences Deal Flow Committee


    Portfolio companies include:

        web link

      Alung Technologies
        web link

        web link

        web link

      Bridge Semiconductor
        web link

      Carmell Therapeutics
        web link

      Certes Networks
        web link

      Cisse Cocoa
        web link

      Columbia Northwest
        web link

      Cryothermic Systems
        web link

      DiaKine Therapeutics
        web link

      Figure8 Surgical
        web link

        web link

        web link

      Gemmus Pharma
        web link

        web link

        web link

        web link

      INRange Management Systems
        web link

      InStream Media
        web link

      Intimate Bridge 2 Conception
        web link

        web link

      medSage Technologies
        web link

      Neuros Medical
        web link

      PetsDx Veterinary Imaging
        web link

      RedPath Integrated Pathology
        web link

        web link

      STARR Life Sciences
        web link

        web link

        web link

      Voci Technologies
        web link

      Westmoreland Advanced Materials
        web link

      Wombat Security Technologies
        web link

      Wright Therapy Products
        web link

      Zone2 Surgical
        web link


    Recent News: